Get notified when MRSH files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: MRSH MARSH & MCLENNAN COMPANIES, INC. 10-Q

Marsh posts 8% revenue growth but earnings fall 15% on $425M Greensill litigation charge

Filed April 16, 2026 · Period ending March 31, 2026 · Compared to 10-Q Apr 17, 2025 · ~1 min read

Key Changes

  • high

    Company recorded $425 million charge for Greensill litigation liability and legal expenses in Q1 2026, driving operating income down 12% to $1.8 billion and diluted EPS down 15% to $2.36 despite 8% revenue growth.

    MD&A: Greensill litigation charge verify on EDGAR →
  • high

    Risk and Insurance Services operating margin compressed from 33.9% to 26.0% year-over-year, primarily due to the Greensill charge allocated to this segment and higher compensation costs.

    MD&A: RIS operating margin verify on EDGAR →
  • medium

    Share repurchases accelerated to $755M (4.2 million shares) in Q1 2026 vs. $300 million in prior year, while quarterly dividend increased 10.4% to $0.900 per share.

    MD&A: Capital allocation verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (CAG 10-K) is open in full — no account needed.

Partner

Trade MRSH commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify